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About half of people with cancer are treated with radiation therapy; however, normal tissue toxicity still remains
a dose-limiting factor for this treatment. The skin response to ionizing radiation may involve multiple
inflammatory outbreaks. The endothelium is known to play a critical role in radiation-induced vascular injury.
Furthermore, endothelial dysfunction reflects a decreased availability of nitric oxide. Statins have been reported
to preserve endothelial function through their antioxidant and anti-inflammatory activities. In this study, wild
type and endothelial nitric oxide synthase (eNOS)/mice were subjected to dorsal skin irradiation and treated
with pravastatin for 28 days. We demonstrated that pravastatin has a therapeutic effect on skin lesions and
abolishes radiation-induced vascular functional activation by decreasing interactions between leukocytes and
endothelium. Pravastatin limits the radiation-induced increase of blood CCL2 and CXCL1 production
expression of inflammatory adhesion molecules such as E-selectin and intercellular adhesion molecule-1,
and inflammatory cell migration in tissues. Pravastatin limits the in vivo and in vitro radiation-induced
downregulation of eNOS. Moreover, pravastatin has no effect in eNOS/mice, demonstrating that eNOS plays
a key role in the beneficial effect of pravastatin in radiation-induced skin lesions. In conclusion, pravastatin may
be a good therapeutic approach to prevent or reduce radiation-induced skin damage.
Journal of Investigative Dermatology (2009) 129, 1280–1291; doi:10.1038/jid.2008.360; published online 12 February 2009
INTRODUCTION
Cutaneous radiation reactions are a limiting factor in radio-
therapy (RT). As many as 95% of patients treated with
radiation therapy for cancer will experience a skin reaction
(De Conno et al., 1991) and less than 10% will have
moist desquamation as measured by the Radiation Therapy
Oncology Group acute scoring system (Porock et al., 1999).
Acute side effects in the skin, such as erythema, edema,
and dry or moist desquamation can be observed during
and within several weeks after RT. The cutaneous symptoms
after radiation exposure are based on a combination of
inflammatory processes and alteration of cellular prolifera-
tion as a result of a specific pattern of transcriptionally
activated proinflammatory cytokines and growth factors:
cytokines released by irradiated cells such as IL-1b
(Liu et al., 2006) or IL-6 (Petit-Frere et al., 2000), chemokines
such as IL-8 and monocyte chemotactic protein-1 (MCP-1;
Benderitter et al., 2007; Kang et al., 2007) bind to receptors
on cells and stimulate them to generate a biological
response. Adhesion molecules (Quarmby et al., 1999) as
well as cellular signaling processes (Calderwood et al., 2000)
are also implicated: intercellular adhesion molecule 1
(ICAM-1), vascular cell adhesion molecule 1 and E-selectin,
three important inflammatory adhesion molecules, partici-
pate in the radiation-induced inflammatory reaction of the
endothelium (Hallahan et al., 1995; Gaugler et al., 1997;
Heckmann et al., 1998; Meineke et al., 2002; Yuan et al.,
2003).
Nitric oxide (NO) is known to preserve endothelial
function during pathophysiological conditions such as
inflammation (Braam and Verhaar, 2007). In fact, NO
regulates leukocyte trafficking by preventing leukocyte
adherence to the endothelium (Kubes et al., 1991; Lefer,
1997). Persistence of endothelial dysfunction was suggested
to be dependent on NO bioavailability disturbed by
irradiation because of the effects of reactive oxygen species
on the endothelium (Hatoum et al., 2006).
Statins have been reported to have beneficial vascular
effects in addition to their cholesterol-lowering properties
(Wolfrum et al., 2003). Statins exert anti-inflammatory action,
particularly by inhibiting endothelial cell activation, that is
adhesion molecule expression such as ICAM-1 (Gaugler
et al., 2005), cytokine (IL-6), and chemokine (MCP-1, IL-8)
production (Gaugler et al., 2005), and by preventing
leukocyte adherence to the endothelium (Pruefer et al.,
1999; Gaugler et al., 2005). Moreover, statins have been
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found to modulate NO synthase (NOS) activity and NO
bioavailability. In this regard, it has been reported that statins
are able to increase expression of endothelial NOS (eNOS)
mRNA and protein in vitro (Laufs et al., 1998) and in vivo (Di
Napoli et al., 2005). The initiation and the maintenance of
endothelial dysfunction play a key role in the pathogenesis of
the radiation response (Wang et al., 2007). Therefore,
improving endothelial cell function after radiation exposure
with pharmacological agents may limit one of the crucial
steps contributing to the pathogenesis of the deleterious
effects.
In this study, we developed a specific experimental
model simulating the skin clinical outcomes observed after
RT. In this model, mice were irradiated with a single high
dose of radiation; nevertheless it simulated the clinical skin
lesions and the histological changes observed after fractio-
nated irradiation (Archambeau et al., 1995). This experi-
mental model allows a precise and reproducible evaluation
of the different grades of lesions described in various
classification systems (Twardella and Chang-Claude, 2002;
Hoeller et al., 2003). Pravastatin was administrated just
after the irradiation to limit the development of skin lesions.
We assessed the effect of irradiation on the functionality of
the endothelium and the ability of pravastatin to modulate
the response of the endothelium to irradiation, that is the
resulting increased interactions with leukocytes. Finally,
the involvement of eNOS in the effect of statin was
investigated.
RESULTS
Characterization of the cutaneous radiation model
Five groups of six wild-type (Wt) Balb/c mice were irradiated
at single doses ranging from 8.5 to 45Gy, and a group of six
was left unirradiated to serve as a control. The skin reaction
was scored every day after irradiation using the arbitrary scale
shown in Figure 1a and was plotted for each dose group as a
function of time.
Wild-type mice did not display any skin reaction after
irradiation at a single dose of 8.5Gy (Figure 1b and c); however,
skin reactions were observed for higher doses. At 17Gy, lesions
appeared at day 11, evolved to slight reddening (erythema), and
returned to a normal state at day 19. At 25Gy, lesions appeared
at day 8, reached severe reddening at day 14, and recovered a
quasi-normal state with a mean score of 0.3 at day 22.
At 45Gy, the skin reaction has started earlier, at day 5,
with an increasing reddening followed by a dry and a moist
desquamation reaching the maximum of the lesion at day
20–21 (Figure 1b and c). Skin lesions finally began to heal
during the last week of experimentation (days 22–28).
Irradiation does not alter wall shear rate within the vessels
Skin venules from sham and irradiated Wt mice were selected
by their mean diameter (50–100 mm) and vessels were
characterized by their wall shear rate, which characterizes
the blood flow, and is calculated from measurement of the
mean red blood cell velocity. The wall shear rate was not
significantly affected by irradiation in this range of vessel
Mouse back skin reaction 
Score                                       Observation
0 Normal 
0.25 50/50 doubtful if there is any difference from normal 
0.5 Very slight reddening 
0.75 Definite but slight reddening 
1 Severe reddening 
1.25 Severe reddening with white scale, "papery" aspect of the skin 
1.5 Moist breakdown in one very small area with scaly or crusty appearance 
1.75 Moist desquamation in more than one small area 
2 Moist desquamation of larger area : 25% of the irradiated area 
2.25 Moist desquamation of larger area : 33% of the irradiated area 
2.5 Moist desquamation of larger area : 50% of the irradiated area 
2.75 Moist desquamation of larger area : 66% of the irradiated area 
3 Moist desquamation of most of the irradiated area 
3.25 Moist desquamation of most of the irradiated area with slight moist exudate 
3.5 Moist desquamation of the irradiated area with moist exudates. Necrosis 
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Figure 1. Characterization of the cutaneous radiation model. (a) The skin reaction scoring system comprised 15 levels, from 0.5 to 3.5 adapted from Douglas
and Fowler (1976). (b) Dorsal skin reaction scores of Wt Balb/c mice at various times following irradiation. Arrows indicated the skin reaction score
corresponding to the representative images of Wt mice in (c) 21 days after exposure at the indicated doses.
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diameter. Mean values calculated at day 28 on 4–6 Wt mice
per group (2–4 measurements per mouse) were 639±39,
641±35, and 574±37 per seconds, respectively, at 0, 17
and 45Gy.
Irradiation increases leukocyte–endothelium interactions
Intravital microscopy was used to visualize leukocyte–
endothelium interactions in the dorsal venules after radiation
exposure. The interactions between leukocytes and endo-
thelial cells were then quantified at days 1, 28, 60, and 90
after radiation exposure. The majority of adherent leukocytes
(rolling and firm adhesion) were neutrophils, as determined
by cellular and nuclear morphology. A significant decrease of
the mean rolling velocity was observed after irradiation,
reaching 2.6-, 1.4-, 2.6-, and 2.1-fold, at days 1, 28, 60, and
90, respectively (Figure 2c, Po0.001). This suggests an
increased interaction of leukocytes with endothelial cells.
No effect of irradiation on the number of rolling
leukocytes was observed at day 1, 60 and 90 (Figure 2d).
Nevertheless, a significant increase (3.9-fold) was observed at
day 28, whereas a significant improvement in the percentage
of circulating neutrophils reached 2.6-fold, (14.8±2.0 vs
37.8±2.8 at 0 and 45Gy, respectively Po0.001). In
addition, concerning firm adhesion, no definitive arrest was
observed at 0Gy, whereas a significant increase was
measured 28 days after radiation exposure (Figure 2e).
Pravastatin improves radiation-induced skin reaction: clinical
benefit
Two groups of eight Wt mice (treated or not with pravastatin)
were either irradiated at a single dose of 45Gy or
left unirradiated to serve as a control. The skin reaction was
scored every day after irradiation and plotted for each
group as a function of time (Figure 3a). Lesions appeared at
day 6 for the 45Gy group, 2 days before the 45Gyþ pra-
vastatin group. Maximum scoring of the lesions was observed
at day 23 for the 45Gy group, with a mean score of 3.2, and
at day 21 for the 45Gyþpravastatin group, with a mean
score of 1.9.
Integration of the 2 curves obtained by plotting the
scoring allows as to estimate an enhancement of the
cutaneous lesions as a benefit of 37%. This benefit can be
confirmed by qualitative morphometry of skin biopsies
(Figure 3b). Whereas the complete destruction of the
epidermis was observed in the center of the lesion for the
irradiated Wt mice (Figure 3b, panel 1), a hypertrophic
epidermis was observed for the 45Gyþ pravastatin Wt
mice (Figure 3b, panel 2). This therapeutic benefit
comes with an improvement of the clinical behavior of Wt
mice. No weight loss was observed in the 45Gyþ
pravastatin group whereas the 45Gy group started to
lose weight at day 12 and had not yet recovered at day 28
(Figure 3c).
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Figure 2. Irradiation increases leukocyte–endothelium interactions. Visualization of leukocyte–endothelium interactions in the dorsal skin vessels by intravital
videomicroscopy after intravenous administration of rhodamine 6G, 28 days after radiation exposure: (a) no irradiation and (b) 45Gy irradiation. Blood
vessels are delineated by dashed lines (scale bar: 40 mm). The rolling velocity (c), the number of rolling leukocytes (R) per minute per 0.01mm2 (d), and the
number of firmly adherent leukocytes (e) were determined by intravital microscopy until 90 days after a 45Gy radiation exposure. Data are expressed as the
mean±SEM of at least three animals per group. **Po0.001 relative to nonirradiated group.
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Pravastatin limits radiation-induced vascular functional
activation
To quantify functional activation of the vascular network, 3
parameters of leukocyte–endothelium interactions were
measured at day 28 by using intravital microscopy (Figure 4).
In irradiated Wt mice, pravastatin increases the rolling
velocity of leukocytes by twofold (Figure 4a). Pravastatin
restores completely the rolling velocity in irradiated Wt mice
as no significant difference was observed compared with
nonirradiated mice treated with pravastatin. Pravastatin acts
by reducing the strength of the interactions between
leukocytes and the endothelium. Figure 4b shows that
pravastatin has no effect on the number of rolling leukocytes
in the irradiated mice, and no significant difference was
observed in the pravastatin groups. Finally, pravastatin
significantly decreases the number of firmly adherent
leukocytes induced by radiation exposure (28 firmly adherent
leukocytes/0.01mm2 vs 1 and 0, respectively, in the 45 and
0Gy group; Figure 4c).
Pravastatin limits the radiation-induced increased production of
inflammatory mediators
In vivo. Measurement of cytokine concentration was
performed on plasma for CCL2 and serum for CXCL1. A
significant radiation-induced increased production of CCL2
and CXCL1 was observed ( 3.3 and 3.0, respectively),
and in both cases, pravastatin completely reversed the CCL2
and CXCL1 production (respectively 0.5 and 0.7, 45Gy
vs 45Gyþpravastatin), as no significant difference was
observed after irradiation in the pravastatin groups (0Gy vs
45Gy; Figure 5a and b).
In vitro. As previously described for microvascular endothe-
lial cells (EC) of other origin (Gaugler et al., 2005), we
confirmed that radiation induced a significantly increased
production of MCP-1 by irradiated human dermal micro-
vascular endothelial cell (HMVEC)-D cells (Figure 5c) from
days 3 to 14 after exposure (D3, 2.4-fold; D7, 2.5-fold,
and D14, 2.2-fold). The production of MCP-1 by irradiated
cells was completely inhibited by pravastatin at days 3 and
14, as the production returned to the basal levels of
nonirradiated cells. We observed an increased production
of IL-8 by HMVEC-D cells 3 days after exposure (Po0.001;
Figure 5d). This effect was significantly maintained at least up
to 14 days after irradiation. Pravastatin limits partially the
production of IL-8 by HMVEC-D at days 3 and 7; however, at
day 14, the effect of paravastatin is complete, as the
production is no different from the basal level obtained in
nonirradiated cells.
Pravastatin limits inflammatory cells in skin
CD45þ cell density was expressed as the number of
inflammatory cells per square millimeter of skin. CD45þ
cell density was increased by 3.9-fold after radiation
exposure at 45Gy in the nontreated groups. Compared to
the nontreated groups, pravastatin significantly reduced this
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Figure 3. Pravastatin improves radiation-induced skin reaction: clinical benefit. (a) Skin-reaction scores of the dorsal skin of mice following 45Gy
irradiation and pravastatin treatment. (b) H&E-stained section of 45Gy irradiated mice dorsal skin (1) without and (2) with pravastatin, 28 days after exposure
(bar: 1mm). The skin between the two arrows corresponds to the irradiated area. (c) Weight is expressed as a relative percentage calculated from
the weight at day 0 for each of the eight Wt mice per group.
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inflammatory infiltration in response to ionizing radiation by
3.8-fold. (Figure 5e).
Pravastatin limits radiation-induced endothelium activation
in vivo
Intercellular adhesion molecule-1 is constitutively expressed
in tissues at a low level and is induced by many stimuli such
as irradiation. In the skin of Wt mice, ICAM-1 labeling was
observed in endothelial cells, both in dermis and hypodermis
(Figure 6a–c). Vessels (100%) are positive for ICAM-1
staining. But the number of vessels positive for ICAM-1 was
significantly lower in the 45Gyþpravastatin group as
compared to the 45Gy group (Table 1).
E-selectin is known to be expressed on activated
endothelium; however, its expression on resting EC has been
observed in the vessels of the mid to upper dermis of the skin
in a nonuniform distribution (Chong et al., 2004). After
irradiation, the majority of vessels are positive in all groups,
in a homogenous localization in the dermis; however, the
number of vessels positive for E-selectin was significantly
lower in the 45Gyþpravastatin group compared with the
45Gy group (Table 1; Figure 6d–f).
Pravastatin limits radiation-induced endothelium activation
in vitro
As described previously for microvascular EC from other
tissue (Gaugler et al., 2001, 2005), radiation upregulated
ICAM-1 on the surface of HMVEC-D cells (Po0.001; Figure
7a). This increase was maintained at least up to 14 days after
irradiation. The radiation-induced upregulation of ICAM-1
was inhibited by pravastatin 3 days after exposure, when
expression returned to the basal level of nonirradiated cells.
Expression of ICAM-1 was partially inhibited at days 7 and 14
by pravastatin: a significant decrease (Po0.001) in the
expression of ICAM-1 was observed at day 14 on the effect
of the 10Gyþ pravastatin, without return to the basal level.
Pravastatin increases the expression of eNOS in vitro
Variations of eNOS protein levels were performed by western
blot analysis on HMVEC-D cells. A decrease in eNOS level
was observed at days 3, 7, and 14 after a 10Gy irradiation
that was partially reversed after treatment with pravastatin
(Figure 7b).
Pravastatin increased eNOS expression after irradiation in vivo
Vessels (85%) were positive in the 45Gy group, whereas 100%
were positive in the nonirradiated and in the 45Gyþ pravas-
tatin groups. The number of vessels positive for eNOS was
significantly higher in the 45Gyþ pravastatin group compared
with the 45Gy group (Table 1 and Figure 6g–i).
Pravastatin has no effect on the radiation-induced skin reaction
of eNOS/ mice
Two of eight groups of eNOS/ mice (treated or not with
pravastatin) were irradiated at a single dose of 45Gy. The
skin reaction was scored every day after irradiation and
plotted for each group as a function of time (Figure 8a).
Lesions appeared at day 4 for the two groups. Maximum
scoring of the lesions was observed at day 14 for the
45Gyþ pravastatin group and at day 17 for the 45Gy group
(Figure 8a and b). The two groups reached the same
maximum scoring of the lesion.
Integration of the two curves obtained by plotting the
scoring has allowed us to estimate no benefit of pravastatin
treatment in the irradiated eNOS/ mice.
DISCUSSION
We demonstrated in this study the role of vascular dysfunc-
tion in the progression of skin lesions after radiation
exposure. Our findings showed that pravastatin limited
radiation-induced vascular dysfunction by decreasing cyto-
kine and adhesion molecule expression, and by increasing
eNOS expression in blood vessels. We underlined the
implication of eNOS in pravastatin treatment with a model
of eNOS-deficient mice.
The inflammation process is one phase of skin wound
healing (Singer and Clark, 1999). Leukocyte recruitment is a
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Figure 4. Pravastatin limits radiation-induced vascular functional activation.
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multistep process, which includes leukocyte rolling, activa-
tion, firm adhesion to the endothelium, and leukocyte
infiltration in the tissue. It contributes to the first step in the
inflammatory response (Lindbom et al., 1992; Quarmby
et al., 1999). Intravital microscopy has proven to be a
powerful method to analyze this inflammatory step in vivo
in physiological and pathological conditions (Panes and
Granger, 1998; Mouthon et al., 2003).
Our results, obtained with a specific experimental model
simulating the clinical outcomes as observed after RT,
underlined the importance of vascular dysfunction during
both acute and late phase skin reactions to radiation.
The first day after exposure, despite any visible clinical
sign, we showed that irradiation induces a significant
decrease in leukocyte rolling velocity, suggesting the initia-
tion of a vascular dysfunction. This vascular dysfunction
observed in vivo is in agreement with the early vascular
activation and cell-surface expression observed after ionizing
radiation in skin organ cultures and cultured human dermal
microvascular endothelial cells (Heckmann et al., 1998).
Many investigators have highlighted the importance of the
first 24 h following irradiation in several experimental
models such as after an abdominal irradiation (Buell and
Harding, 1989; Panes et al., 1995; Molla et al., 2003;
Johnson et al., 2004) and a brain irradiation (Yuan et al.,
2003, 2005), suggesting that vascular dysfunction is main-
tained.
In this study, we underlined the persistent vascular
dysfunction throughout the progression of skin lesions (from
days 1 to 22), during healing and after (from days 22 to 90).
We demonstrated that at day 28, as the skin lesion was in the
progress of healing, the rolling velocity of leukocytes still
remained decreased. Interestingly, at day 90, as the lesion
was no more apparent, the rolling velocity of leukocytes
remain decreased, suggesting a persistent interaction be-
tween the endothelium and leukocytes. This persistent
vascular dysfunction observed in vivo was confirmed by the
functional activation observed in vitro, 21 days after radiation
exposure, in a model of cultured human microvascular
endothelial cells in a flow chamber perfusion system
(Vereycken-Holler et al., 2002). The maintenance of such a
response could contribute to the development and progres-
sion of late vascular and tissue radiation damage (Molla et al.,
2003). In addition, the inflammatory response to ionizing
radiation was confirmed by increased production of CXCL1
and CCL2 in mouse serum and plasma at day 28,
the significant increase of firmly adherent leukocytes in
blood vessels associated with the rise in infiltrated CD45þ
cells in skin. This was confirmed by our in vitro model, with
persistent increased production of IL-8 and MCP-1 up to 14
days after radiation exposure (this study and Gaugler et al.,
2005).
Our results established the vascular dysfunction induced
by local skin irradiation. We therefore considered the
Table 1. Immunolabeling of the skin blood vessels1
after pravastatin administration, 28 days after a local
irradiation
eNOS E-selectin ICAM-1
Positive vessels/field
(mean±SEM)
45Gy 5.6±0.4 15.2±0.7 13.0±0.5
45Gy+pravastatin 11.8±0.6 7.7±0.4 10.5±0.5
Mann–Whitney test 45
vs 45Gy+pravastatin
Po0.001 Po0.001 Po0.001
eNOS, endothelial nitric oxide synthase; ICAM-1, intercellular adhesion
molecule-1; SEM, standard error of mean.
1Stained blood vessels were counted in 16 different fields at a 20
magnification for each mouse of each group. Mean value was obtained for
each immunostaining. The statistical analysis was performed employing
the Mann–Whitney rank-sum test to compare the different groups (45Gy
vs 45Gy+pravastatin).
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pharmacological modulation of this dysfunction to limit skin
toxicity after irradiation.
In addition to their cholesterol-lowering properties, statins
exert pleiotropic, vasculoprotective actions that include
improvement of endothelial function (John et al., 2005),
increased NO bioavailability (Laufs et al., 1998), antioxidant
properties (Mason et al., 2006), and stabilization of athero-
sclerotic plaques (Rezaie-Majd et al., 2002). In addition,
several studies showed the inhibition of inflammatory
responses (Greenwood and Mason, 2007) and immunomo-
dulatory actions (Kwak et al., 2000; Mulhaupt et al., 2003).
We demonstrated that pravastatin improved endothelium
function and tissue repair after radiation exposure. This
inhibitory effect in the recruitment and firm adhesion of
leukocytes by the vascular endothelium required for the
following leukocyte transmigration is the consequence of a
modulation of the expression of endothelial cell adhesion
molecules by statins. Statins have been shown to be
implicated in a reduction in P- and E-selectin that promotes
leukocyte rolling in vitro (Omi et al., 2003) and in vivo
(Pruefer et al., 1999; Cha et al., 2004). Statins also affect the
expression of cell adhesion molecules, ICAM-1 and vascular
cell adhesion molecule 1, that are directly involved in
leukocyte adhesion and diapedesis (Sadeghi et al., 2000). To
confirm intravital results, our data demonstrated in the same
way that pravastatin limits the radiation-induced increased
expression of ICAM-1 and E-selectin in skin vessels by
immunohistochemistry.
Vessels (100%) were positive for ICAM-1 staining and a
vasodilatation of the skin vessels was observed after irradia-
tion, suggesting that small vessels that are not visible in less
inflammatory conditions, that is 45Gyþpravastatin, are
more visible in inflammatory conditions, that is 45Gy
irradiation, thus explaining this apparent decrease in the
number of vessels per field after pravastatin treatment.
In a previous in vitro study, we demonstrated that
pravastatin downregulates the early radiation-induced activa-
tion of transcription factor AP1 in human microvascular
endothelial cells and cytokines (IL-6, IL-8), chemokine (MCP-
1), and adhesion molecule (ICAM-1; Gaugler et al., 2005).
The role of NO in leukocyte recruitment is supported by its
significant role in the prevention of an endothelial dysfunc-
tion observed in vivo (Kubes et al., 1991; Gauthier et al.,
1995; Scalia et al., 1999) and by the failure of statins to
inhibit leukocyte–endothelium interactions in eNOS-deficient
mice (Stalker et al., 2001).
Our study suggests that a persistent drop in NO bioavail-
ability could result until day 28 in a chronic endothelium
activation. In the present in vitro study, western blot analysis
shows that pravastatin partially inhibited the radiation-
induced decrease of eNOS expression in HMVEC-D cells 3
days after a 10Gy irradiation. These observations have also
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Figure 8. Pravastatin has no effect on the radiation-induced skin reaction of eNOS/ mice. Skin-reaction scores of the dorsal skin of eNOS/ mice following
a 45Gy irradiation or a 45Gy irradiationþ pravastatin treatment (a). Arrows indicated the skin reaction score corresponding to the representative images of
eNOS/ mice 14 days after exposure (b).
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been described in the irradiated blood vessels and are in
agreement with the fact that the decreased eNOS expression
after irradiation is associated with the endothelial inflamma-
tory response (Qi et al., 1998). We observed an increase in
ICAM-1 expression and in MCP-1 and IL-8 release after a
10Gy irradiation in HMVEC-D cells that is partly abolished
for ICAM-1, MCP-1, and IL-8 after pravastatin treatment.
These in vitro data are corroborated by the decrease in the
radiation-induced production of CXCL1 and CCL2 observed
in vivo. Immunostaining of irradiated skin shows that
pravastatin limits the increased radiation-induced expression
of ICAM-1 and E-selectin in the skin vessel in association with
an increase in eNOS expression. These results support the
role of eNOS in the maintenance of vascular dysfunction after
radiation exposure. Its implication as an important mechan-
ism by which pravastatin improves the deleterious effects of
irradiation is confirmed by the absence of the clinical benefit
of pravastatin in the model of irradiated eNOS-deficient
mice. Nevertheless, in an interesting way, an upregulation of
eNOS was described in bovine aortic endothelial cells but
only during the first 48 hours after irradiation and with a
20Gy maximum exposure to ionizing radiation (Sonveaux
et al., 2003). The differences in radiation dose ranges and
time after exposure could explain the contrast with our
results.
In conclusion, to our knowledge, this study of an
experimental mouse model that showed a persistent en-
dothelium activation after skin irradiation in vivo is pre-
viously unreported. These data suggest that inhibiting
endothelial dysfunction with pravastatin may limit the
initiation and the progression of skin lesions with activation
of NO bioavailability. These data contribute to the knowl-
edge of skin toxicity after RT treatment. We are aware of the
limitation of this experimental model because of the high
single dose of radiation, but the similarity of skin lesions
obtained following single high doses of irradiation and those
resulting from cumulated fractionated doses has already been
established (Archambeau et al., 1995). Moreover, some experi-
mental pharmacological studies on the skin were developed with
a single high dose of radiation: the effect of curcumin on the
acute and chronic skin toxicity was studied after a single dose
of 50Gy (Okunieff et al., 2006), and the effect of esculentoside
A was tested on radiation-induced cutaneous toxicity after a
single dose of 30Gy (Xiao et al., 2006). Pravastatin appears to
be a very interesting molecule and a fractionated model of
irradiation could be interesting to develop. Future research is
needed to exclude any adverse effects on tumor cells, and
experiments have already suggested that pravastatin can be
used in cancer patients to protect against delayed intestinal
toxicity without protecting tumors (Haydont et al., 2007). In
fact, pravastatin may be then proposed as a new therapeutic
approach to prevent the severity of normal skin injury without
compromising– and even improving–tumor control.
MATERIALS AND METHODS
Animal models and study protocols
Mice. Wild-type male Balb/c mice, 7 weeks old, (Janvier, France)
and eNOS-deficient (eNOS/) mice (Charles River Laboratories,
France) were housed four to a cage and received commercial rodent
chow and acidified water ad libitum. Two days before irradiation,
mice weighing 19–22 g were anesthetized by spontaneous inhalation
of isoflurane-N2O (FiO20.35, 0.015 l l
1 isoflurane, Forene, Abbott
GmbH, Wiesbaden, Germany). The entire back was shaved and
remaining roots were removed with hair depilatory cream on each
animal.
For the characterization of the experimental model, five groups of
six mice were irradiated at single doses ranging from 8.5 to 45Gy,
and a group of six was left unirradiated to serve as a control. For the
pharmacological study, Wt Balb/c mice were randomly divided into
four groups of eight Wt mice: (1) sham (2) shamþ pravastatin (3)
45Gy, and (4) 45Gyþ pravastatin. eNOS/ mice were randomly
divided into two groups of eight mice: (5) 45Gy, and (6)
45Gyþ pravastatin. Pravastatin (40mg kg1 per day, ELISOR,
Bristol-Myers Squibb) was administered daily in the food from days
0, immediately after the irradiation, (D0: day of irradiation) to 28
(D28). Every day, mice were isolated to check that they ate all the
food containing the pravastatin.
Animal model of irradiation
All experimental procedures were approved by the animal care
committee of the Institute of Radioprotection and Nuclear Safety and
conformed to the French regulation for animal experimentation (act
no. 2001-464, 29 May 2001).
Before irradiation, mice were anesthetized by intraperitoneal
injection of a mixture of ketamine (100mg kg1) and xylazine
(10 mg kg1). Mice were laid onto a Plexiglas device; the dorsal skin
was gently stretched and maintained with two suturing lines. The
area of the dorsal skin exposed to the ionizing radiation corresponds
to a surface of 2 4 cm.
Irradiation was given as a local single exposure (1.5Gy per
minute) using a 60Co source (ICO 4000, IRSN, France). Sham-
irradiated mice were handled such as irradiated mice but were not
exposed to the radiation source. After irradiation, mice returned to
the cages in which they were housed in a climate-controlled
environment with free access to food and water. Mice were observed
daily until day 28 for pravastatin experiments and until day 90 for the
others following radiation exposure.
Daily clinical scoring of the lesion
The system used to score the skin reactions has been adapted from
Douglas and Fowler (1976). Using the arbitrary scale shown in
Figure 1a, the scoring system comprised 15 levels, from normal (0) to
necrosis (3.5). Mice were daily scored by two ‘‘blind’’ experimen-
ters, and the average daily reaction was plotted against time for
each group.
Intravital microscopy
Mice were anesthetized by intraperitoneal injection of 2.5%
tribromoethanol (0.15ml per 10 g body weight, Sigma-Aldrich,
France) and leukocytes were stained by intravenous administration
of 10.4% rhodamin 6G (62.5 ml per mouse, Sigma-Aldrich).
The animals were maintained at 37 1C on a heating-pad during
the whole experiment. A dorsal skin flap was dissected free from the
body and was placed in a 5% gelatin-coated Plexiglas chamber for
observation of dorsal microcirculation. By preserving all the vessels
on one side of this flap from the cranial side to the caudal side, blood
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circulation was maintained in this part and allowed visualization
and quantification of leukocyte–endothelial interactions.
Red blood cell velocity was measured using an optical Doppler
velocimeter (Microcirculation Research Institute, College Station,
TX) as previously described (Mouthon et al., 2003). Venular shear
rates (g) were calculated using the venular diameter (D) and RBC
velocity (V) with the following formula: g¼ 8(Vmean/D), where
Vmean¼V/1.6. Following 5minutes stabilization time after IV
injection of rhodamin 6G, 50–100mm diameter venules were
selected for direct observation of leukocyte–endothelium inter-
actions. Briefly, venules were visualized with an Eclipse TE-300
fluorescence inverted microscope (Nikon) equipped with a  40
objective, a 100-W HBO fluorescent lamp source and a silicon-
intensified tube camera (C2400, Hamamatsu) connected to a DSR-
20MDP digital videotape recorder (Sony). Venules were filmed for
5–10minutes and video recording was resumed for another venule
(up to four vessels were analyzed for each mouse).
Image analysis
Three parameters of leukocyte–endothelium interactions were
measured by intravital microscopy: (1) the mean leukocyte rolling
velocity, (2) the number of rolling leukocytes, and (3) the number of
firmly adherent leukocytes. Rolling leukocytes were defined as any
leukocytes observed translating along the venular wall in contact
with the endothelium that were moving slower than the hydro-
dynamic critical velocity Vcrit defined by Ley and Gaehtgens (1991).
Vcrit, calculated for each venule, is the velocity of a cell that is no
more rolling but sliding pulling by the flow.
Quantification of leukocyte–endothelial interactions (rolling and
firm adhesion) was made using the software Histolab 4.3.6
(Microvision Instruments, Evry, France). A leukocyte was considered
to be adherent when it was stationary on the endothelium for more
than 1minute. Leukocyte–endothelial interactions were analyzed
during 1–4minutes per vessel within a square of 25 25 mm2,
50 50mm2, or 100 100mm2 depending on the vessel diameter
and quantifications were normalized thereafter per minute per
0.01mm2.
Quantitative histopathology and morphometry
Skin biopsies. Two skin samples per mouse were taken as 8 8mm
biopsies from the center of the skin flap and corresponding to the
center area of the lesion. The first sample was fixed in 4%
formaldehyde and embedded in paraffin for histological assessments
and immunohistochemistry (four to six mice per group), and the
second sample (for leukocyte staining) was embedded in Tissue-Tek
OCT compound (Sakura Finetek, Zoeterwoude, the Netherlands),
snap frozen in liquid nitrogen and stored at 80 1C for immuno-
labeling.
Histological examinations and immunohistochemistry methods
The paraffin-embedded skin was cut into 5mm sections, deparaffi-
nized, hydrated, dehydrated, and stained with hematoxylin, eosin,
and safran for histological examinations: quantification of epider-
mal, dermal, and hypodermal thickness was carried out by capturing
images of hematoxylin-, eosin-, and safran-stained sections ( 2.5
and  10 objective) from a Zeiss Axiophot microscope using a JVC
video color camera KY-F50. The thickness of each section was
measured using Visiol@b 2000 image analysis software (BIOCOM
SA, Les Ulis, France). On each sample, seven distinct fields were
quantified and quantitative results are expressed as mean±standard
error of mean (SEM).
The CD45 immunohistochemical staining was performed on a
Ventana Nexes system (Ventana Medical Systems SA, Tucson, AZ;
Van der Meeren et al., 2005). Polyclonal rat antimouse CD45 IgG
antibody (BD Pharmingen, San Jose, CA) was used at 1:1500 to
identify leukocytes. Quantification of leukocytes was expressed as
the number of CD45þ cells per square millimeter tissue.
Immunohistochemical staining using rabbit polyclonal anti-
mouse NOS3 (eNOS) IgG antibody (1:500, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), chicken anti-mouse CD62E (E-selectin) IgG
antibody (1:5, R&D Systems, Minneapolis, MN), and goat polyclonal
anti-mouse CD54 (ICAM-1) IgG antibody (1:100, R&D Systems)
were performed on the paraffin-embedded skin sections. Specificity
of immunohistochemical staining was demonstrated by the absence
of staining products using a nonimmune corresponding immunoglo-
blin. The number of vessels positive (strongly stained and lightly
stained) for eNOS, E-selectin, and ICAM-1 was counted indepen-
dently by two authors and expressed as the number of positive
vessels per unit surface. The surface of the tissue analyzed,
corresponding to a field ( 20 magnification), was determined using
an image analysis software (Visiol@b 2000). In total, 16 fields per
mouse and 4 mice per group were analyzed.
Quantification of cytokine production (ELISA) and adhesion
molecule expression (cell ELISA)
In vivo. Quantitative determinations of CXCL1 and CCL2,
respectively, in serum and plasma of mice were performed using a
sandwich ELISA according to the manufacturer’s recommendations
(R&D Systems). All serum and plasma samples for each mouse were
stored at 80 1C and were measured at the same time by the same
ELISA to avoid variation of assay conditions. Detection limits of
ELISA assays were as follows: CCL2, 91 to 152 pgml1 and CXCL1,
111 to 185 pgml1.
In vitro. Primary HMVEC-D were obtained from Clonetics
(Cambrex, Emerainville, France), seeded at density of 5000 cells
per cm2, and routinely cultured at 37 1C in 5% CO2 according to the
vendor recommendations in the supplier’s endothelial cell growth
culture medium-2-MV, referred to here as a complete medium.
HMVEC-D cells were used between the fifth and seventh passage.
Cells were allowed to reach confluence before irradiation. Just
before irradiation, the culture medium was replaced with complete
medium containing pravastatin (100 mM final concentration), kindly
provided by Bristol-Myers Squibb. HMVEC-D were uniformly
irradiated with a single dose of 10Gy of g-radiation delivered from
a 60Co source (ICO 4000, IRSN, dose rate of 1.5Gy per minute).
Sham-irradiated control HMVEC-D cells were treated under the
same conditions (Gaugler et al., 2005). Pravastatin was added
each time the cultured medium was changed after irradiation (days
3, 7, 10).
Intercellular adhesion molecule-1 expression was determined as
described previously (Gaugler et al., 2001), using cell ELISA on
paraformaldehyde-fixed HMVEC-D cells in 24-well plates. The cells
were first incubated with primary antibody (Beckman Coulter,
Fullerton, CA) for 1 hour at 20 1C and then with a peroxidase-
conjugated secondary antibody (Jackson, Suffolk, UK) for 1 hour at
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20 1C. Absorbance was measured at 492 nm on a microplate reader
(Bio-Tek Instruments). For each time, the number of cells was
determined after trypsinization of the monolayer.
Quantitative determinations of IL-8 and MCP-1 in supernatants of
HMVEC-D cells cultured in 24-well plates were performed using a
sandwich ELISA according to the manufacturer’s recommendations
(R&D Systems). For each time, the number of cells was determined
after trypsinization of the monolayer.
Western blot analysis
The following protein-specific primary antibody was used: anti-
NOS3 (eNOS) ((C-20): SC-654, Santa Cruz Biotechnology) and anti-
glyceraldehyde-3-phosphate dehydrogenase (Biodesign, Saco, ME).
Proteins were separated by SDS-PAGE before being transferred onto
nitrocellulose membranes. The membranes were blotted with
primary antibody, followed by incubation with secondary antibody
HRP conjugated (Amersham, Orsay, France). Blots were developed
using the enhanced chemiluminescence method (Amersham).
Membranes were then dehybridized and reprobed with anti-
glyceraldehyde-3-phosphate dehydrogenase to detect glyceralde-
hyde-3-phosphate dehydrogenase expression as control loading.
Data analysis
Results are presented as means±SEM. Statistical significance was
assessed by Student’s t- or Mann–Whitney test (Sigma Stat 3.0, Jandel
Scientific). Differences were accepted as statistically significant at
Po0.05.
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